OMTX705, a Novel FAP-Targeting ADC Demonstrates Activity in Chemotherapy and Pembrolizumab-Resistant Solid Tumor Models.
Clin Cancer Res
; 26(13): 3420-3430, 2020 07 01.
Article
in En
| MEDLINE
| ID: mdl-32161121
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Immunoconjugates
/
Drug Resistance, Neoplasm
/
Membrane Proteins
/
Antineoplastic Agents
Limits:
Animals
/
Humans
Language:
En
Journal:
Clin Cancer Res
Journal subject:
NEOPLASIAS
Year:
2020
Document type:
Article